Case of malignant melanoma responding to dacarbazine following nivolumab.

MLA

Saito, Ryo, et al. “Case of Malignant Melanoma Responding to Dacarbazine Following Nivolumab.” Dermatologic Therapy, vol. 32, no. 2, Mar. 2019, p. e12791. EBSCOhost, https://doi.org/10.1111/dth.12791.

APA

Saito, R., Kawai, M., Hirakawa, K., Tanaka, M., Takahagi, S., & Hide, M. (2019). Case of malignant melanoma responding to dacarbazine following nivolumab. Dermatologic Therapy, 32(2), e12791. https://doi.org/10.1111/dth.12791

Chicago

Saito, Ryo, Mikio Kawai, Kayoko Hirakawa, Maiko Tanaka, Shunsuke Takahagi, and Michihiro Hide. 2019. “Case of Malignant Melanoma Responding to Dacarbazine Following Nivolumab.” Dermatologic Therapy 32 (2): e12791. doi:10.1111/dth.12791.